News

Hims & Hers Health (NYSE:HIMS) stock fell 4.1% in after-hours trading on Thursday following a Bloomberg report that revealed ...
Telehealth company Hims & Hers Health’s ($HIMS) business practices have been under investigation by the U.S. Federal Trade ...
The US health sector is bustling with activity. Key developments include an FTC investigation into Hims & Hers' practices, ...
For more than a year, the Federal Trade Commission has been investigating Hims & Hers Health Inc.’s business practices, including whether it has made it too hard for customers to cancel subscriptions, ...
Hims & Hers Health (NYSE:HIMS) stock fell 5% in after-hours trading on Thursday following a Bloomberg report that revealed ...
Telehealth and wellness platform Hims & Hers Health ($HIMS) recently disappointed investors with its mixed second-quarter ...
The U.S. Federal Trade Commission is probing complaints about Telehealth platform Hims & Hers regarding its advertising and ...
The U.S. Federal Trade Commission is probing complaints about telehealth platform Hims & Hers regarding its advertising and ...
Insider moves in IonQ, Hims and Hers, Eli Lilly, and TransMedics reveal bold buys, record sales, and signals worth watching.
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.
In a Georgia courtroom that could’ve easily been heavy with nothing but pain and anger, widow Regina Johnson shocked ...
Doctors report insurance cuts are forcing many U.S. patients on Wegovy and Zepbound to pay high out-of-pocket costs.